ith prescription drug prices continuing to strain state budgets, the National Governors Association is planning a meeting later this year to explore strategies for lowering costs, notably for hepatitis C drugs. And payers and drug makers will be invited, according to one state official familiar with the plan.

Details have not been disclosed, but the effort reflects ongoing concern that some medicines remain out of reach for people who rely on cash-strapped state Medicaid programs, according to Dr. Rebekah Gee, the Louisiana Department of Health secretary, who has been involved in the planning.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.